Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease
- 1 November 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 29 (5), 370-391
- https://doi.org/10.2165/00003088-199529050-00005
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Cetirizine Pharmacokinetics and Pharmacodynamics in Primary Biliary CirrhosisThe Journal of Clinical Pharmacology, 1993
- P450 EnzymesClinical Pharmacokinetics, 1992
- Pharmacokinetics of Temafloxacin in Patients with Liver Impairment†Clinical Pharmacokinetics, 1992
- Clinical Pharmacokinetics in Patients with Liver DiseaseClinical Pharmacokinetics, 1991
- Comparison of Adinazolam Pharmacokinetics and Effects in Healthy and Cirrhotic SubjectsThe Journal of Clinical Pharmacology, 1991
- Quantifying Hepatic Function in the Presence of Liver Disease with Phenazone (Antipyrine) and its MetabolitesClinical Pharmacokinetics, 1991
- Drug disposition in patients with HBsAg-positive chronic liver diseaseDigestive Diseases and Sciences, 1987
- Diseases and Drug Protein BindingClinical Pharmacokinetics, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Propranolol Disposition in Chronic Liver DiseaseClinical Pharmacokinetics, 1976